AADI Stock Data and Insider Activity
AADI - Aadi Bioscience, Inc. Common Stock Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site.
Chart and Financial Data provided by TradingView
Whale Activity

Recently reported position changes by institutional investors

Senate Trading

Recent trades by U.S. Senators

No data for this ticker
House Trading

Recent trades by U.S. Representatives

No data for this ticker
Insider Trading

Quarterly net insider trading by a company's directors and management

Corporate Flights

Flights by private jets registered to AADI

No data for this ticker
Government Contracts

Federal grants, loans, and purchases. Click on a date for more info.

Date Agency Amount

2022-07-23 00:00:00

2022-07-23 00:00:00
Number of mentions of AADI in WallStreetBets Daily Discussion
Date Mentions
9/1/2021 3
11/23/2021 2
U.S. Patents

New patents grants by month

No data for this ticker
Off-Exchange Trading

Yesterday's off-exchange activity

No data for this ticker
Corporate Lobbying

Government lobbying spending instances

No data for this ticker
CNBC Recommendations

Recent picks made for AADI on CNBC

No data for this ticker
Top ETF Holders

ETFs with the largest estimated holdings in AADI

ETF Ticker ETF Name Est. Holding Size
VTI Vanguard $4.8 million
IWM iShares $2.6 million
VXF Vanguard $2.0 million
IWO iShares $882473
VTWO Vanguard $416971
IWC iShares $245914
VTWG Vanguard $124161
SBIO ALPS $115893
DFAS Dimensional $43620
RYLD Global X $43346
DFAT Dimensional $37060
BTEC Principal $30754
DFAU Dimensional $14661
VTHR Vanguard $7937
URTY ProShares $6806
UWM ProShares $4837
NTKI Nationwide $539
HDG ProShares $288
ITOT iShares $138